BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28122729)

  • 1. Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated β-catenin degradation.
    Ninsontia C; Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
    Am J Physiol Cell Physiol; 2017 Apr; 312(4):C487-C499. PubMed ID: 28122729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
    Phiboonchaiyanan PP; Chanvorachote P
    Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.
    Ei ZZ; Racha S; Yokoya M; Hotta D; Zou H; Chanvorachote P
    Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
    Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
    J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F; Wu X; Jiang X; Qian Y; Gao J
    J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
    Srinual S; Chanvorachote P; Pongrakhananon V
    Int J Oncol; 2017 Apr; 50(4):1341-1351. PubMed ID: 28259926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell-like population is preferentially suppressed by EGFR-TKIs in EGFR-mutated PC-9 tumor models.
    Yang F; Li Y; Liu B; You J; Zhou Q
    Exp Cell Res; 2018 Jan; 362(1):195-202. PubMed ID: 29154817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.
    Chung LY; Tang SJ; Wu YC; Sun GH; Liu HY; Sun KH
    Oncotarget; 2015 Mar; 6(7):4936-52. PubMed ID: 25669973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma.
    Heng WS; Cheah SC
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
    Green R; Howell M; Khalil R; Nair R; Yan J; Foran E; Katiri S; Banerjee J; Singh M; Bharadwaj S; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Dec; 9(1):18177. PubMed ID: 31796785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
    Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
    Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
    Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
    Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ti
    Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
    Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J; Wu S; Wu H; Li L; Guo T
    Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.